Suppr超能文献

开发、分析和解读结果评估以改善传染病临床研究中的终点指标。

Developing, Analyzing, and Interpreting Outcome Assessments to Improve Endpoints in Infectious Diseases Clinical Research.

作者信息

Powers John H, O'Connell Robert J

机构信息

Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.

Department of Medicine, George Washington University School of Medicine, Washington, District of Columbia, USA.

出版信息

Clin Infect Dis. 2025 Aug 6;81(Supplement_1):S4-S10. doi: 10.1093/cid/ciaf319.

Abstract

Evidence from clinical research studies, in addition to patient values and clinical experience, helps practitioners best apply medical interventions to clinical practice. Part of evaluating the evidence is understanding the outcomes used as endpoints in research studies. The most direct evidence of patient benefit comes from endpoints that evaluate the effects of interventions on patient survival, symptoms, and function, and the impact of symptoms and function on health-related quality of life. In this article, we discuss how to develop endpoints for clinical research studies focusing on patient-reported outcome measures, including those measuring patient symptoms, function, and health-related quality of life. We discuss the process for determining (1) which concepts to measure, including which concepts are most relevant to patients (content validity); (2) who performs the measurement and which measurement properties to use (construct validity); and (3) how to analyze and interpret the results obtained using the chosen measurements.

摘要

除了患者价值观和临床经验外,临床研究的证据有助于从业者将医学干预措施最佳地应用于临床实践。评估证据的一部分是理解在研究中用作终点的结果。患者受益的最直接证据来自于评估干预措施对患者生存、症状和功能的影响,以及症状和功能对健康相关生活质量的影响的终点。在本文中,我们讨论如何为专注于患者报告结局测量的临床研究制定终点,包括那些测量患者症状、功能和健康相关生活质量的测量。我们讨论确定以下内容的过程:(1)测量哪些概念,包括哪些概念与患者最相关(内容效度);(2)谁进行测量以及使用哪些测量属性(结构效度);以及(3)如何分析和解释使用所选测量获得的结果。

相似文献

4
Interventions for interpersonal communication about end of life care between health practitioners and affected people.
Cochrane Database Syst Rev. 2022 Jul 8;7(7):CD013116. doi: 10.1002/14651858.CD013116.pub2.
6
Using longitudinal qualitative research to explore the experience of receiving and using augmentative and alternative communication.
Int J Lang Commun Disord. 2024 May-Jun;59(3):1043-1065. doi: 10.1111/1460-6984.12981. Epub 2023 Nov 14.
7
Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
Cochrane Database Syst Rev. 2018 Jan 3;1(1):CD010908. doi: 10.1002/14651858.CD010908.pub2.
8
Outcomes of specialist physiotherapy for functional motor disorder: the Physio4FMD RCT.
Health Technol Assess. 2025 Jul;29(34):1-28. doi: 10.3310/MKAC9495.
9
Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.
Cochrane Database Syst Rev. 2014 Apr 29;2014(4):CD007768. doi: 10.1002/14651858.CD007768.pub3.

本文引用的文献

2
Recommendations to address respondent burden associated with patient-reported outcome assessment.
Nat Med. 2024 Mar;30(3):650-659. doi: 10.1038/s41591-024-02827-9. Epub 2024 Feb 29.
4
Evidence at time of regulatory approval and cost of new antibiotics in 2016-19: cohort study of FDA approved drugs.
BMJ Med. 2022 Dec 12;1(1):e000227. doi: 10.1136/bmjmed-2022-000227. eCollection 2022.
8
Structured patient interview to assess clinical outcomes in complicated urinary tract infections in the APEKS-cUTI study: pilot investigation.
Ther Adv Infect Dis. 2021 Nov 24;8:20499361211058257. doi: 10.1177/20499361211058257. eCollection 2021 Jan-Dec.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验